These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 14722483)

  • 1. Designated case managers as facilitators of medical and psychosocial service delivery in addiction treatment programs.
    Friedmann PD; Hendrickson JC; Gerstein DR; Zhang Z
    J Behav Health Serv Res; 2004; 31(1):86-97. PubMed ID: 14722483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical and psychosocial services in drug abuse treatment: do stronger linkages promote client utilization?
    Friedmann PD; D'Aunno TA; Jin L; Alexander JA
    Health Serv Res; 2000 Jun; 35(2):443-65. PubMed ID: 10857471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barriers to enrollment in drug abuse treatment and suggestions for reducing them: opinions of drug injecting street outreach clients and other system stakeholders.
    Appel PW; Ellison AA; Jansky HK; Oldak R
    Am J Drug Alcohol Abuse; 2004; 30(1):129-53. PubMed ID: 15083558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementing methadone medical maintenance in community-based clinics: disseminating evidence-based treatment.
    King VL; Burke C; Stoller KB; Neufeld KJ; Peirce J; Kolodner K; Kidorf M; Brooner RK
    J Subst Abuse Treat; 2008 Oct; 35(3):312-21. PubMed ID: 18294805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of primary medical care on addiction and medical severity in substance abuse treatment programs.
    Friedmann PD; Zhang Z; Hendrickson J; Stein MD; Gerstein DR
    J Gen Intern Med; 2003 Jan; 18(1):1-8. PubMed ID: 12534757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of case management in the publicly funded substance abuse treatment system. The perspective of program directors, case managers and clients.
    Shwartz M; Stone DA; Camp J; Mulvey KP; Kane M; Plough A
    Care Manag J; 2000; 2(3):139-47. PubMed ID: 11398569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender differences in the impact of comprehensive services in substance abuse treatment.
    Marsh JC; Cao D; D'Aunno T
    J Subst Abuse Treat; 2004 Dec; 27(4):289-300. PubMed ID: 15610830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using the DATCAP and ASI to estimate the costs and benefits of residential addiction treatment in the State of Washington.
    French MT; Salomé HJ; Carney M
    Soc Sci Med; 2002 Dec; 55(12):2267-82. PubMed ID: 12409139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do mechanisms that link addiction treatment patients to primary care influence subsequent utilization of emergency and hospital care?
    Friedmann PD; Hendrickson JC; Gerstein DR; Zhang Z; Stein MD
    Med Care; 2006 Jan; 44(1):8-15. PubMed ID: 16365607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychiatric comorbidity measures as predictors of retention in drug abuse treatment programs.
    Broome KM; Flynn PM; Simpson DD
    Health Serv Res; 1999 Aug; 34(3):791-806. PubMed ID: 10445903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefit determination under managed care for substance abuse treatment clients.
    McNeese-Smith DK; Crook MW; Marinelli-Casey P; Williams L; Rawson R
    Care Manag J; 2001-2002 Winter; 3(2):55-62. PubMed ID: 12455215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case management within substance abuse treatment programs in Los Angeles County.
    McNeese-Smith DK
    Care Manag J; 1999; 1(1):10-8. PubMed ID: 10835792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in Medicaid Fee-for-Service Benefit Design for Substance Use Disorder Treatment During the Opioid Crisis, 2014 to 2021.
    Shoulders A; Andrews CM; Westlake MA; Abraham AJ; Grogan CM
    JAMA Health Forum; 2023 Aug; 4(8):e232502. PubMed ID: 37566428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linkage to medical services in the Drug Abuse Treatment Outcome Study.
    Friedmann PD; Lemon SC; Stein MD; Etheridge RM; D'Aunno TA
    Med Care; 2001 Mar; 39(3):284-95. PubMed ID: 11242322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of case management in substance abuse treatment services for women and their children.
    Brindis CD; Theidon KS
    J Psychoactive Drugs; 1997; 29(1):79-88. PubMed ID: 9110268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The contribution of consensus within staff and client groups as well as concordance between staff and clients to treatment engagement.
    Melnick G; Wexler HK; Chaple M; Banks S
    J Subst Abuse Treat; 2006 Oct; 31(3):277-85. PubMed ID: 16996390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An organizational analysis of service patterns in outpatient drug abuse treatment units.
    D'Aunno T; Vaughn TE
    J Subst Abuse; 1995; 7(1):27-42. PubMed ID: 7655310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Provision of drug treatment services in the juvenile justice system: a system reform.
    Terry YM; VanderWaal CJ; McBride DC; Van Buren H
    J Behav Health Serv Res; 2000 May; 27(2):194-214. PubMed ID: 10795129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Program structure and counselor-client contact in outpatient substance abuse treatment.
    Knight DK; Broome KM; Simpson DD; Flynn PM
    Health Serv Res; 2008 Apr; 43(2):616-34. PubMed ID: 18370970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.